Neurotech S.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Neurotech S.A. - overview
Established
1996
Location
Louvain-la-Neuve, -, Belgium
Primary Industry
Medical Devices & Equipment
About
Neurotech S. A. develops innovative neurotechnology solutions aimed at enhancing cognitive functions and mental health through advanced neurofeedback systems and brain-computer interfaces. Founded in 1996 and headquartered in Louvain-la-Neuve, Belgium, Neurotech S.
A. specializes in neurotechnology solutions that enhance cognitive functions. The company has undergone strategic shifts to focus on advanced neurofeedback systems and brain-computer interface devices. It was acquired by Sorin Group in November 2012 for an undisclosed amount.
The CEO is Susan Powers. Neurotech S. A. specializes in a variety of neurotechnology solutions designed to improve cognitive function and mental health.
Their principal offerings include advanced neurofeedback systems and brain-computer interface devices, enabling users to monitor and adjust their brain activity. Targeting healthcare professionals, educational institutions, and individual consumers, their products are actively marketed in Belgium, Germany, the Netherlands, as well as in North America and Asia. In the most recent fiscal year of 2012, Neurotech S. A.
reported a revenue of EUR 1,222,533. 30, with an EBITDA loss of EUR 1,138,544. 70. Their revenue model is built on direct-to-consumer sales and B2B partnerships, focusing on neurofeedback systems and related services, allowing for both one-time purchases and subscription-based access for ongoing support.
Neurotech S. A. aims to expand its product line with new neurotechnology offerings and is actively targeting new geographic markets for growth. The funding from its latest round in November 2012 will support these initiatives, facilitating the development of new products and entry into additional regions.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors
Website
www.neurotech.be
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Neurotech S.A. - financials
| Fiscal Year Ended | Dec 31, 2003 | Dec 31, 2004 | Dec 31, 2005 | Dec 31, 2006 | Dec 31, 2007 | Dec 31, 2008 | Dec 31, 2009 | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | 26,101 | 24,755 | (82,879) | (161,341) | (175,272) | (263,252) | (354,248) | - | - | - |
| Operating Income (USD) | 10,835 | 9,019 | (119,876) | (188,274) | (204,641) | (293,015) | (384,188) | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - | - | - | - | - |
| NET Income (USD) | 8,171 | 5,274 | 118,095 | (196,417) | (222,830) | (323,586) | (373,781) | - | - | - |
| % Net Margin | - | - | - | - | - | - | - | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.